Clarus Therapeutics (CRXTW) News Today → Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad) Free CRXTW Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineANTX AN2 Therapeutics, Inc.seekingalpha.com - March 26 at 7:41 PMClarus Corp.wsj.com - April 5 at 1:31 PMClarus Therapeutics Holdings, Inc. (CRXWQ)ca.finance.yahoo.com - March 24 at 2:05 AMEarnings Preview For Clarusmsn.com - February 26 at 1:02 PMCRXTQ Clarus Therapeutics Holdings, Inc.seekingalpha.com - January 21 at 4:38 PMClarus Therapeutics Holdings, Inc. (CRXTQ)ca.finance.yahoo.com - November 18 at 10:56 PMClarus Therapeutics Hldgs Stock (OTC:CRXTQ), Guidance and Forecastbenzinga.com - September 26 at 11:58 PMFirm Retention Summary: Clarus Therapeutics Holdings Inc.wsj.com - September 16 at 3:38 PMClarus files for chapter 11 bankruptcy, eyes auction of testosterone therapy Jatenzoseekingalpha.com - September 7 at 11:05 PMWhy Clarus Corp. Stock Plummeted on Mondaynasdaq.com - August 29 at 6:10 PMClarus Board of Directors Approves Two of Its Top Shareholders to Increase Their Positions up to 12.5% of Shares Outstandingfinance.yahoo.com - August 22 at 10:32 AMClarus Therapeutics Cuts Staff, Evaluates Strategic Alternativesmarketwatch.com - August 18 at 9:11 PMClarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reductionfinance.yahoo.com - August 18 at 4:11 PM Get Clarus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRXTW and its competitors with MarketBeat's FREE daily newsletter. Email Address The Long-Awaited End of America Update (Ad)A 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it. Click here to find out for free. CRXTW Media Mentions By Week CRXTW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRXTW News Sentiment▼0.000.36▲Average News Sentiment CRXTW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRXTW Articles This Week▼00▲CRXTW Articles Average Week Get Clarus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRXTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRXTW) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingA once-in-a-century investment opportunityStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clarus Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
